Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Turcot syndrome × sintilimab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Stomach Neoplasms 8 Carcinoma, Non-Small-Cell Lung 5 Pancreatic Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Thyroid Neoplasms 1 Solid Tumor 1 Recurrence 1 Pancreatic Cancer Resectable 1 Pancreatic Cancer Metastatic 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Lung Squamous Cell Carcinoma 1 Locally Recurrent Rectal Cancer 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Rectal Cancer 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 Hemangiosarcoma 1 Gastric Adenocarcinoma 1

Interventions

pembrolizumab 8 Nivolumab 6 Ipilimumab 3 durvalumab 2 atezolizumab 2 Specimen Handling 2 toripalimab 1 relatlimab 1 fludarabine phosphate 1 fludarabine 1 danvatirsen 1 avelumab 1 Surgical Procedures, Operative 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Interleukin-2 1 Induction Chemotherapy 1 Immunotherapy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 IMM-101 1 Docetaxel 1 Disulfides 1 Diffusion Tensor Imaging 1 DEAE-Dextran 1 Cyclophosphamide 1 Colonoscopy 1 Chemotherapy, Adjuvant 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡